Related Experiment Videos
Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study
Gil Y Melmed1, Robert Elashoff, Gary C Chen
1Inflammatory Bowel Disease Center, Division of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California Los Angeles, California, USA.
Predicting a change from ulcerative colitis (UC) to Crohn's disease (CD) is crucial. Non-bloody diarrhea and significant weight loss at initial presentation are key indicators for potential diagnostic shifts in inflammatory bowel disease (IBD).
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease (IBD) Research
- Diagnostic Predictors
Background:
- Some patients initially diagnosed with ulcerative colitis (UC) are later reclassified as having Crohn's disease (CD).
- Identifying predictors for this diagnostic change can refine patient management strategies for colonic inflammation.
Purpose of the Study:
- To identify clinical and serologic predictors that indicate a diagnostic change from UC to CD.
- To characterize factors associated with misdiagnosis between UC and CD.
Main Methods:
- A nested case-controlled study compared patients who changed diagnosis from UC to CD (cases) with UC and CD controls.
- Clinical 'red flags' were reviewed, and serum was tested for specific antibodies (e.g., anti-Saccharomyces cerevisiae, perinuclear antineutrophil cytoplasmic antibodies).
Main Results:
- Three clinical 'red flags' differed between cases and UC controls, but no serologic markers were significant predictors.
- Extensive colonic involvement at initial colonoscopy was more common in cases (P = .008).
- Non-bloody diarrhea (P = .01) and weight loss >10% (P = .007) at initial presentation independently predicted a diagnostic change, with serologic markers not improving prediction accuracy.
Conclusions:
- Patients with UC presenting with non-bloody diarrhea or significant weight loss have a higher likelihood of being rediagnosed with CD.
- These clinical factors may warrant closer diagnostic evaluation for patients with suspected inflammatory bowel disease.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...